Jupiter, FL [March 9, 2026] — Myosin Therapeutics today announced it has been invited to present at two upcoming South Florida life sciences events highlighting emerging biotechnology innovation and regional industry growth. On March 10, the company will participate in the Investival Showcase: South...
Read moreJupiter, FL [January 27, 2026]. Myosin Therapeutics today announced it has been selected to present at Biocom California’s Global Partnering & Investor Conference, taking place February 24–26, 2026 at The Lodge at Torrey Pines in La Jolla, California. In addition to one-on-one partnering meeting...
Read moreJupiter, FL — [November 2025] — Myosin Therapeutics, Inc. announced today that Courtney Miller, PhD, Chief Executive Officer and co-founder, and Karen Smith, MD, PhD, Chief Medical Officer, will attend the 2025 Society for Neuro-Oncology (SNO) Annual Meeting this November. While at SNO, Dr. Miller a...
Read moreJupiter, FL - [May 5th, 2024] – Myosin Therapeutics is proud to announce that Dr. Courtney Miller, CEO and Chair of the Board of Directors, will speak at the BIO International Convention in “Breaking the Cycle: Innovations in Addressing Substance Use Disorder.” The session will bring together leadin...
Read moreJupiter, FL - [January 15th, 2023] – Myosin Therapeutics is honored to announce its selection to present at the prestigious Florida Venture Forum, a premier gathering of the state’s venture capital and private equity professionals. Dr. Pat Griffin, Co-Founder and Member of the Board of Directors at ...
Read more